ECVT · Ecovyst Inc. - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · ECVT

1Y 3Y 5Y Max

Annual Quarterly

Income Statement

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$723.51M	$704.49M	$691.12M	$820.16M	$611.20M	$1.11B
Cost of Revenue	$565.43M	$502.97M	$493.15M	$595.53M	$434.54M	$834.01M
Gross Profit	$158.09M	$201.52M	$197.97M	$224.63M	$176.66M	$273.36M
R&D	-	$6.81M	$7.80M	$7.23M	$7.50M	$11.60M
SG&A	$66.02M	$83.88M	$79.22M	$85.33M	$97.78M	$125.29M
Total Operating Expenses	$27.18M	$19.55M	$22.10M	$34.91M	$24.27M	$50.99M
D&A	$67.81M	$89.36M	$84.60M	$79.16M	$79.74M	$151.84M
Operating Income	$64.89M	$98.09M	$96.65M	$104.39M	$54.61M	($162.92M)
Interest Expense	$34.20M	$49.43M	$44.73M	$37.22M	$36.99M	$66.98M
Income Tax	$19.50M	$1.63M	$10.79M	$24.94M	$12.15M	($48.12M)
Net Income	($71.13M)	($6.65M)	$71.15M	$73.70M	($139.95M)	($278.77M)
EPS - Basic	($0.62)	($0.06)	$0.60	$0.55	($1.03)	($2.06)
EPS - Diluted	($0.61)	($0.06)	$0.60	$0.55	($1.02)	($2.06)

Balance Sheet

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Cash & Equivalents	$197.19M	$146.01M	$88.36M	$110.92M	$140.89M	$135.53M
Accounts Receivable	$85.31M	$77.94M	$81.31M	$74.76M	$80.80M	$132.62M
Inventory	$26.80M	$57.13M	$45.12M	$44.36M	$53.81M	$127.44M
Accounts Payable	$48.05M	$43.93M	$40.20M	$40.02M	$51.86M	$112.33M
Current Assets	$319.36M	$303.71M	$245.99M	$267.70M	$291.67M	$428.14M
Total Assets	$1.26B	$1.80B	$1.84B	$1.88B	$1.93B	$3.20B
Current Liabilities	$120.81M	$115.13M	$119.08M	$129.40M	$145.08M	$201.34M
Long-term Debt	$392.58M	$852.10M	$858.95M	$865.87M	$872.84M	$1.40B
Total Liabilities	$657.54M	$1.10B	$1.13B	$1.18B	$1.19B	$1.92B
Stockholders' Equity	$603.44M	$700.46M	$705.46M	$707.23M	$740.74M	$1.28B
Retained Earnings	($248.63M)	($177.51M)	($170.86M)	($242.01M)	($315.71M)	($175.76M)

Cash Flow

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Operating Cash Flow	$140.31M	$149.89M	$137.60M	$186.61M	$129.92M	$223.60M
Investing Cash Flow	$435.41M	($73.45M)	($65.33M)	($63.02M)	$835.73M	$551.47M
Financing Cash Flow	($524.96M)	($17.84M)	($93.50M)	($148.19M)	($964.23M)	($722.82M)
CapEx	$70.41M	$68.95M	$65.33M	$58.87M	$60.05M	$97.14M
Free Cash Flow	$69.89M	$80.94M	$72.26M	$127.74M	$69.87M	$126.46M

Ratios

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Profitability
Gross margin	21.8%	28.6%	28.6%	27.4%	28.9%	24.7%
Operating margin	9.0%	13.9%	14.0%	12.7%	8.9%	-14.7%
EBITDA margin	18.3%	26.6%	26.2%	22.4%	22.0%	-1.0%
Net margin	-9.8%	-0.9%	10.3%	9.0%	-22.9%	-25.2%
Free cash flow margin	9.7%	11.5%	10.5%	15.6%	11.4%	11.4%
FCF / Net income	-0.98	-12.17	1.02	1.73	-0.50	-0.45
R&D / Revenue	-	1.0%	1.1%	0.9%	1.2%	1.0%
SG&A / Revenue	9.1%	11.9%	11.5%	10.4%	16.0%	11.3%
Effective tax rate	-	-	13.2%	25.3%	-	-
Return on assets	-5.6%	-0.4%	3.9%	3.9%	-7.2%	-8.7%
Return on equity	-11.8%	-0.9%	10.1%	10.4%	-18.9%	-21.8%
Return on invested capital	5.1%	5.0%	5.4%	5.0%	2.7%	-4.8%
Liquidity
Current ratio	2.64	2.64	2.07	2.07	2.01	2.13
Quick ratio	2.42	2.14	1.69	1.73	1.64	1.49
Cash ratio	1.63	1.27	0.74	0.86	0.97	0.67
Leverage
Debt / Equity	0.65	1.22	1.22	1.22	1.18	1.10
Debt / Assets	0.31	0.47	0.47	0.46	0.45	0.44
Debt / EBITDA	2.96	4.55	4.74	4.72	6.50	-
Interest coverage	1.9x	2.0x	2.2x	2.8x	1.5x	-2.4x
Equity multiplier	2.09	2.57	2.61	2.66	2.61	2.50
Liabilities / Assets	0.52	0.61	0.62	0.62	0.62	0.60
Efficiency
Asset turnover	0.57	0.39	0.38	0.44	0.32	0.35
Inventory turnover	21.10	8.80	10.93	13.42	8.08	6.54
Days sales outstanding	43d	40d	43d	33d	48d	44d
Days inventory outstanding	17d	41d	33d	27d	45d	56d
Days payable outstanding	31d	32d	30d	25d	44d	49d
Cash conversion cycle	29d	50d	47d	36d	50d	50d
Valuation
P / E	-	-	16.3x	16.1x	-	-
P / B	1.9x	1.3x	1.7x	1.7x	1.9x	1.5x
P / S	1.6x	1.3x	1.7x	1.5x	2.3x	1.7x
EV / EBITDA	10.0x	8.5x	10.7x	10.6x	15.9x	-
Growth
Revenue growth (YoY)	2.7%	1.9%	-15.7%	34.2%	-44.8%	-29.3%
Revenue CAGR (3y)	-4.1%	4.8%	-14.5%	-19.4%	-16.9%	-
Revenue CAGR (5y)	-8.2%	-14.8%	-8.3%	-	-	-
Gross profit growth (YoY)	-21.6%	1.8%	-11.9%	27.2%	-35.4%	-30.0%
Operating income growth (YoY)	-33.9%	1.5%	-7.4%	91.2%	-	-
Net income growth (YoY)	-969.2%	-	-3.5%	-	49.8%	-
EPS growth (YoY)	-916.7%	-	9.1%	-	50.5%	-
EPS CAGR (3y)	-	-	-	-2.3%	-	-
EPS CAGR (5y)	-	-	6.9%	-	-	-
FCF growth (YoY)	-13.6%	12.0%	-43.4%	82.8%	-44.7%	-9.7%
FCF CAGR (5y)	-11.2%	-10.4%	-9.2%	-	-	-
Book value growth (YoY)	-13.9%	-0.7%	-0.2%	-4.5%	-42.0%	-28.2%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-12-31.

Product / service

$723.51M total

Regeneration And Treatment Services$361.24M · 49.9%

Industrial Mining Automotive$327.94M · 45.3%

Other Services$34.34M · 4.7%

Stability scores

Altman Z′

FY 2025 · bankruptcy risk

1.06

Distress

Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.

Piotroski F-score

FY 2025 · 9-point quality

6/9

Neutral

✗Net income positive
✓Operating cash flow positive
✗ROA improved YoY
✓Cash flow > net income
✓Long-term debt decreased
✓Current ratio improved
✓No share dilution
✗Gross margin improved
✓Asset turnover improved

Peer comparison

Same SIC group: Chemicals & Allied Products

Company	Revenue (last FY)	Net margin	ROE
FMC	$3.47B	-64.6%	-108.1%
CC	$5.81B	-6.6%	-154.4%
OLN	$6.78B	-1.5%	-5.5%
NGVT	$1.17B	-14.3%	-562.6%
IOSP	$1.78B	6.6%	8.8%

Comparing Ecovyst Inc. against the 5 most active filers in the same SIC group.

Dividends

$0.00/share trailing 12 months

Ex-date	Per share
Aug 11, 2021	$3.2000
Dec 18, 2020	$1.8000